MSOSAdvisorShares Pure US Cannabis ETF

Grow my money5y track recordRanked #815 of 2,960 in this goal

Seeks long-term capital appreciation through investments in U.S. cannabis-related companies.

By AdvisorShares · Launched 2020

Annual Cost

0.78%

#3,926 of 5,562 · expensive

Fund Size

$1.0B

#1,108 of 5,562 · large

Return (1Y)Goal

+125.8%

Track Record

5 years

#2,173 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$23,538+135.4%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Multi strategy

What it actually holds

By weight

Concentration

Top 1 holdings = 12.3% of fund✓ well diversified

Curaleaf Holdings IncCURA

12.3%

Asset allocation

Cash

72.1%

Stocks

17.9%

Other

8.0%

Bonds

2.0%

By sector

Real Estate

50.2%

Industrials

29.6%

Consumer Cyclical

17.8%

Healthcare

2.5%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

112.6%High

Year-on-year price swings

Max drawdown

-96.2%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.36Below average

Sortino (3Y)

0.59Moderate downside risk

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks long-term capital appreciation through investments in U.S. cannabis-related companies.
Strategy: Invests primarily in equity securities of companies deriving significant revenue from the marijuana and hemp business in the U.S. Focuses on mid- and small-cap companies, utilizing total return swaps for exposure. Concentrates at least 25% of assets in the pharmaceuticals, biotechnology & life sciences industry.
Inception date: September 1, 2020
Fund family: AdvisorShares